New Drugs May Influence Social Behaviors in Those With Autism

THURSDAY, May 2, 2019 -- Balovaptan, an orally administered selective vasopressin V1a receptor antagonist, is associated with improved adaptive behaviors for men with autism spectrum disorder (ASD), while arginine vasopressin (AVP), a neuropeptide...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news